Bis([(2S,5R)-2-[5-(azetidin-3-yloxymethyl)-1,2-oxazol-3-yl]-7-oxospiro[1,6-diazabicyclo[3.2.1]octane-4,1'-cyclopropane]-6-yl] hydrogen sulfate);3-bromoprop-1-yne;tert-butyl 3-hydroxyazetidine-1-carboxylate;tert-butyl 3-[[3-[(2S,5R)-6-hydroxy-7-oxospiro[1,6-diazabicyclo[3.2.1]octane-4,1'-cyclopropane]-2-yl]-1,2-oxazol-5-yl]methoxy]azetidine-1-carboxylate;tert-butyl 3-oxoazetidine-1-carboxylate;tert-butyl 3-[[3-[(2S,5R)-7-oxo-6-phenylmethoxyspiro[1,6-diazabicyclo[3.2.1]octane-4,1'-cyclopropane]-2-yl]-1,2-oxazol-5-yl]methoxy]azetidine-1-carboxylate;tert-butyl 3-[[3-[(2S,5R)-7-oxo-6-sulfooxyspiro[1,6-diazabicyclo[3.2.1]octane-4,1'-cyclopropane]-2-yl]-1,2-oxazol-5-yl]methoxy]azetidine-1-carboxylate;tert-butyl 3-prop-2-ynoxyazetidine-1-carboxylate;ethane;(2S,5R)-2-[(E)-hydroxyiminomethyl]-6-phenylmethoxyspiro[1,6-diazabicyclo[3.2.1]octane-4,1'-cyclopropane]-7-one
C145H203BrN26O47S3 — CID 172981604
Data last refreshed: (MolForge compound catalog, from PubChem)
About Bis([(2S,5R)-2-[5-(azetidin-3-yloxymethyl)-1,2-oxazol-3-yl]-7-oxospiro[1,6-diazabicyclo[3.2.1]octane-4,1'-cyclopropane]-6-yl] hydrogen sulfate);3-bromoprop-1-yne;tert-butyl 3-hydroxyazetidine-1-carboxylate;tert-butyl 3-[[3-[(2S,5R)-6-hydroxy-7-oxospiro[1,6-diazabicyclo[3.2.1]octane-4,1'-cyclopropane]-2-yl]-1,2-oxazol-5-yl]methoxy]azetidine-1-carboxylate;tert-butyl 3-oxoazetidine-1-carboxylate;tert-butyl 3-[[3-[(2S,5R)-7-oxo-6-phenylmethoxyspiro[1,6-diazabicyclo[3.2.1]octane-4,1'-cyclopropane]-2-yl]-1,2-oxazol-5-yl]methoxy]azetidine-1-carboxylate;tert-butyl 3-[[3-[(2S,5R)-7-oxo-6-sulfooxyspiro[1,6-diazabicyclo[3.2.1]octane-4,1'-cyclopropane]-2-yl]-1,2-oxazol-5-yl]methoxy]azetidine-1-carboxylate;tert-butyl 3-prop-2-ynoxyazetidine-1-carboxylate;ethane;(2S,5R)-2-[(E)-hydroxyiminomethyl]-6-phenylmethoxyspiro[1,6-diazabicyclo[3.2.1]octane-4,1'-cyclopropane]-7-one
Bis([(2S,5R)-2-[5-(azetidin-3-yloxymethyl)-1,2-oxazol-3-yl]-7-oxospiro[1,6-diazabicyclo[3.2.1]octane-4,1'-cyclopropane]-6-yl] hydrogen sulfate);3-bromoprop-1-yne;tert-butyl 3-hydroxyazetidine-1-carboxylate;tert-butyl 3-[[3-[(2S,5R)-6-hydroxy-7-oxospiro[1,6-diazabicyclo[3.2.1]octane-4,1'-cyclopropane]-2-yl]-1,2-oxazol-5-yl]methoxy]azetidine-1-carboxylate;tert-butyl 3-oxoazetidine-1-carboxylate;tert-butyl 3-[[3-[(2S,5R)-7-oxo-6-phenylmethoxyspiro[1,6-diazabicyclo[3.2.1]octane-4,1'-cyclopropane]-2-yl]-1,2-oxazol-5-yl]methoxy]azetidine-1-carboxylate;tert-butyl 3-[[3-[(2S,5R)-7-oxo-6-sulfooxyspiro[1,6-diazabicyclo[3.2.1]octane-4,1'-cyclopropane]-2-yl]-1,2-oxazol-5-yl]methoxy]azetidine-1-carboxylate;tert-butyl 3-prop-2-ynoxyazetidine-1-carboxylate;ethane;(2S,5R)-2-[(E)-hydroxyiminomethyl]-6-phenylmethoxyspiro[1,6-diazabicyclo[3.2.1]octane-4,1'-cyclopropane]-7-one (PubChem CID 172981604) has the molecular formula C145H203BrN26O47S3 and a molecular weight of 3238.46 g/mol. Its IUPAC name is bis([(2S,5R)-2-[5-(azetidin-3-yloxymethyl)-1,2-oxazol-3-yl]-7-oxospiro[1,6-diazabicyclo[3.2.1]octane-4,1'-cyclopropane]-6-yl] hydrogen sulfate);3-bromoprop-1-yne;tert-butyl 3-hydroxyazetidine-1-carboxylate;tert-butyl 3-[[3-[(2S,5R)-6-hydroxy-7-oxospiro[1,6-diazabicyclo[3.2.1]octane-4,1'-cyclopropane]-2-yl]-1,2-oxazol-5-yl]methoxy]azetidine-1-carboxylate;tert-butyl 3-oxoazetidine-1-carboxylate;tert-butyl 3-[[3-[(2S,5R)-7-oxo-6-phenylmethoxyspiro[1,6-diazabicyclo[3.2.1]octane-4,1'-cyclopropane]-2-yl]-1,2-oxazol-5-yl]methoxy]azetidine-1-carboxylate;tert-butyl 3-[[3-[(2S,5R)-7-oxo-6-sulfooxyspiro[1,6-diazabicyclo[3.2.1]octane-4,1'-cyclopropane]-2-yl]-1,2-oxazol-5-yl]methoxy]azetidine-1-carboxylate;tert-butyl 3-prop-2-ynoxyazetidine-1-carboxylate;ethane;(2S,5R)-2-[(E)-hydroxyiminomethyl]-6-phenylmethoxyspiro[1,6-diazabicyclo[3.2.1]octane-4,1'-cyclopropane]-7-one.
Molecular Properties
| Compound Name | Bis([(2S,5R)-2-[5-(azetidin-3-yloxymethyl)-1,2-oxazol-3-yl]-7-oxospiro[1,6-diazabicyclo[3.2.1]octane-4,1'-cyclopropane]-6-yl] hydrogen sulfate);3-bromoprop-1-yne;tert-butyl 3-hydroxyazetidine-1-carboxylate;tert-butyl 3-[[3-[(2S,5R)-6-hydroxy-7-oxospiro[1,6-diazabicyclo[3.2.1]octane-4,1'-cyclopropane]-2-yl]-1,2-oxazol-5-yl]methoxy]azetidine-1-carboxylate;tert-butyl 3-oxoazetidine-1-carboxylate;tert-butyl 3-[[3-[(2S,5R)-7-oxo-6-phenylmethoxyspiro[1,6-diazabicyclo[3.2.1]octane-4,1'-cyclopropane]-2-yl]-1,2-oxazol-5-yl]methoxy]azetidine-1-carboxylate;tert-butyl 3-[[3-[(2S,5R)-7-oxo-6-sulfooxyspiro[1,6-diazabicyclo[3.2.1]octane-4,1'-cyclopropane]-2-yl]-1,2-oxazol-5-yl]methoxy]azetidine-1-carboxylate;tert-butyl 3-prop-2-ynoxyazetidine-1-carboxylate;ethane;(2S,5R)-2-[(E)-hydroxyiminomethyl]-6-phenylmethoxyspiro[1,6-diazabicyclo[3.2.1]octane-4,1'-cyclopropane]-7-one |
|---|---|
| PubChem CID | 172981604 |
| Molecular Formula | C145H203BrN26O47S3 |
| Molecular Weight | 3238.46 g/mol |
| Exact Mass | 3235.26 |
| IUPAC Name | bis([(2S,5R)-2-[5-(azetidin-3-yloxymethyl)-1,2-oxazol-3-yl]-7-oxospiro[1,6-diazabicyclo[3.2.1]octane-4,1'-cyclopropane]-6-yl] hydrogen sulfate);3-bromoprop-1-yne;tert-butyl 3-hydroxyazetidine-1-carboxylate;tert-butyl 3-[[3-[(2S,5R)-6-hydroxy-7-oxospiro[1,6-diazabicyclo[3.2.1]octane-4,1'-cyclopropane]-2-yl]-1,2-oxazol-5-yl]methoxy]azetidine-1-carboxylate;tert-butyl 3-oxoazetidine-1-carboxylate;tert-butyl 3-[[3-[(2S,5R)-7-oxo-6-phenylmethoxyspiro[1,6-diazabicyclo[3.2.1]octane-4,1'-cyclopropane]-2-yl]-1,2-oxazol-5-yl]methoxy]azetidine-1-carboxylate;tert-butyl 3-[[3-[(2S,5R)-7-oxo-6-sulfooxyspiro[1,6-diazabicyclo[3.2.1]octane-4,1'-cyclopropane]-2-yl]-1,2-oxazol-5-yl]methoxy]azetidine-1-carboxylate;tert-butyl 3-prop-2-ynoxyazetidine-1-carboxylate;ethane;(2S,5R)-2-[(E)-hydroxyiminomethyl]-6-phenylmethoxyspiro[1,6-diazabicyclo[3.2.1]octane-4,1'-cyclopropane]-7-one |
| SMILES | C#CCBr.C#CCOC1CN(C(=O)OC(C)(C)C)C1.CC.CC(C)(C)OC(=O)N1CC(=O)C1.CC(C)(C)OC(=O)N1CC(O)C1.CC(C)(C)OC(=O)N1CC(OCc2cc([C@@H]3CC4(CC4)[C@@H]4CN3C(=O)N4O)no2)C1.CC(C)(C)OC(=O)N1CC(OCc2cc([C@@H]3CC4(CC4)[C@@H]4CN3C(=O)N4OCc3ccccc3)no2)C1.CC(C)(C)OC(=O)N1CC(OCc2cc([C@@H]3CC4(CC4)[C@@H]4CN3C(=O)N4OS(=O)(=O)O)no2)C1.O=C1N2C[C@H](N1OCc1ccccc1)C1(CC1)C[C@H]2/C=N/O.O=C1N2C[C@H](N1OS(=O)(=O)O)C1(CC1)C[C@H]2c1cc(COC2CNC2)on1.O=C1N2C[C@H](N1OS(=O)(=O)O)C1(CC1)C[C@H]2c1cc(COC2CNC2)on1 |
| InChI | InChI=1S/C27H34N4O6.C20H28N4O9S.C20H28N4O6.C16H19N3O3.2C15H20N4O7S.C11H17NO3.C8H15NO3.C8H13NO3.C3H3Br.C2H6/c1-26(2,3)36-25(33)29-13-20(14-29)34-17-19-11-21(28-37-19)22-12-27(9-10-27)23-15-30(22)24(32)31(23)35-16-18-7-5-4-6-8-18;1-19(2,3)31-18(26)22-8-13(9-22)30-11-12-6-14(21-32-12)15-7-20(4-5-20)16-10-23(15)17(25)24(16)33-34(27,28)29;1-19(2,3)29-18(26)22-8-13(9-22)28-11-12-6-14(21-30-12)15-7-20(4-5-20)16-10-23(15)17(25)24(16)27;20-15-18-10-14(16(6-7-16)8-13(18)9-17-21)19(15)22-11-12-4-2-1-3-5-12;2*20-14-18-7-13(19(14)26-27(21,22)23)15(1-2-15)4-12(18)11-3-9(25-17-11)8-24-10-5-16-6-10;1-5-6-14-9-7-12(8-9)10(13)15-11(2,3)4;2*1-8(2,3)12-7(11)9-4-6(10)5-9;1-2-3-4;1-2/h4-8,11,20,22-23H,9-10,12-17H2,1-3H3;6,13,15-16H,4-5,7-11H2,1-3H3,(H,27,28,29);6,13,15-16,27H,4-5,7-11H2,1-3H3;1-5,9,13-14,21H,6-8,10-11H2;2*3,10,12-13,16H,1-2,4-8H2,(H,21,22,23);1,9H,6-8H2,2-4H3;6,10H,4-5H2,1-3H3;4-5H2,1-3H3;1H,3H2;1-2H3/b;;;17-9+;;;;;;;/t22-,23-;2*15-,16-;13-,14-;2*12-,13-;;;;;/m000000...../s1 |
| InChIKey | FNWUVQLHSOZQJT-DIHRQEOTSA-N |
| XLogP | 16.08 |
| TPSA | 827.51 Ų |
| H-Bond Donors | 8 |
| H-Bond Acceptors | 52 |
| Rotatable Bonds | 35 |
| Heavy Atoms | 222 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3238.46 |
| LogP ≤ 5 | 16.08 |
| H-Bond Donors ≤ 5 | 8 |
| H-Bond Acceptors ≤ 10 | 52 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'alkyl_halide', 'substructure': 'N/A'}, {'alert_name': 'hydroxamic_acid', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'oxime_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 172981604 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.